Climate change is rapidly altering the agricultural landscape, leaving farmers scrambling to adjust. As temperatures rise, ...

Shares of early-stage biotech stocks, including Biohaven ( BHVN -6.50%), Recursion Pharmaceuticals ( RXRX -7.37%), and CRISPR ...

CRISPR-based POC testing, transparent soil and the best RNA extraction protocol for archival fixed tissue samples.

"These cells co-develop together, just like they would in an actual embryo, and establish that history of being neighbors," Shariati said. "We do not change their genome or expose them to specific ...

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

A team of researchers at Karolinska Institutet has developed a novel tool for genetic research. The study, published in ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...

Bacteria steal DNA from silent viruses and use it like a memory bank. That memory helps them protect future generations.

IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a ...

All three companies are early-stage biotechnology companies working on next-generation therapeutics with advanced ...

CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Platform to support genetic target ...